In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentratio...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Kohlhoff, S. A., Roblin, P. M., Reznik, T., Hawser, S., Islam, K., Hammerschlag, M. R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2004
Onderwerpen:
Susceptibility
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC400585/
https://ncbi.nlm.nih.gov/pubmed/15105151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1885-1886.2004
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items